Vijaya Diagnostic Centre Limited
Nippon India Mutual Fund decreased its stake in Vijaya Diagnostic Centre Limited from 6.92% to 5.64%, selling 1,317,537 shares. The value of the sold shares was ₹195.54 crore at a price of ₹1482.40 apiece.
A leading diagnostic healthcare provider in Southern India, Vijaya Diagnostics Centre operates a network of diagnostic centers and reference laboratories serving patients across multiple cities. The company delivers comprehensive services including nuclear medicine, radiology, laboratory testing, health check-ups, and medical consultations. Its widespread infrastructure and diverse service offerings position it as a prominent player in the diagnostic healthcare sector.
India's fifth-largest AMC with over Rs 6 lakh crore in AUM, backed by Japan's Nippon Life Insurance which holds majority stake. Formerly Reliance MF, rebranded in 2019 after Nippon's acquisition. Sailesh Raj Bhan has run the equity book for over two decades and is one of India's most experienced active managers. Known for sector rotational calls and a deep research bench.